These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32355492)

  • 1. Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy.
    Nakao Y; Tamauchi S; Yoshikawa N; Suzuki S; Kajiyama H; Kikkawa F
    Case Rep Oncol; 2020; 13(1):373-378. PubMed ID: 32355492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Small Cell Carcinoma of the Uterine Cervix Responding to Combined Therapy with Paclitaxel, Cisplatin, and Bevacizumab: A Case Report.
    Hirasawa T; Kajiwara H; Machida H; Iida T; Ikeda M; Shida M; Mikami M
    Tokai J Exp Clin Med; 2018 Sep; 43(3):81-84. PubMed ID: 30191540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular dendritic cell sarcoma of the uterine cervix: a case report.
    Nakamura T; Yoshihara M; Tamauchi S; Kajiyama H; Kikkawa F
    BMC Womens Health; 2020 Aug; 20(1):182. PubMed ID: 32807169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
    Ling C; Shen Y
    J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal treatment for glassy cell carcinoma of the uterine cervix.
    Nasu K; Takai N; Narahara H
    J Obstet Gynaecol Res; 2009 Jun; 35(3):584-7. PubMed ID: 19527406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports.
    Shoji T; Takeshita R; Mukaida R; Takatori E; Nagasawa T; Omi H; Sugiyama T
    Mol Clin Oncol; 2018 Aug; 9(2):173-177. PubMed ID: 30101016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced papillary serous carcinoma of the uterine cervix: a case with a remarkable response to paclitaxel and carboplatin combination chemotherapy.
    Ueda M; Koshiyama M; Yamaguchi A; Ukita S; Ukita M; Hishikawa K; Kakui K; Kim T; Shirase T
    Rare Tumors; 2012 Jan; 4(1):e1. PubMed ID: 22532907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
    Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
    Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of uterine carcinosarcoma which was strongly suspected to have metastases to the psoas and gluteus muscles.
    Ishidera Y; Yoshida H; Oi Y; Katayama K; Ando N; Shigeta H
    Int Cancer Conf J; 2018 Oct; 7(4):121-124. PubMed ID: 31149529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell carcinoma of the lower uterine segment: A case report.
    Matoba Y; Kisu I; Saotome K; Katayama M; Taniguchi M; Miura Y; Goto T; Hirao N
    Mol Clin Oncol; 2016 Dec; 5(6):701-704. PubMed ID: 28101349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix.
    Tangjitgamol S; Manusirivithaya S; Choomchuay N; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P
    J Obstet Gynaecol Res; 2007 Apr; 33(2):218-24. PubMed ID: 17441901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated endometrial carcinoma of the uterus: marked effect of chemotherapy with tetrahydropyranyl-adriamycin, paclitaxel, and carboplatin.
    Hayashi M; Ueda Y; Takimoto T; Ohkura T
    Int J Gynecol Cancer; 2004; 14(2):388-94. PubMed ID: 15086745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin.
    Hirashima Y; Kobayashi H; Nishiguchi T; Miura K; Kanayama N
    Anticancer Drugs; 2001 Aug; 12(7):627-30. PubMed ID: 11487720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant combined paclitaxel and carboplatin chemotherapy for glassy cell carcinoma of the uterine cervix: report of three cases with clinicopathological analysis.
    Takahashi Y; Sasaki H; Mogami H; Hamada S; Konishi I
    J Obstet Gynaecol Res; 2011 Dec; 37(12):1860-3. PubMed ID: 21955049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030).
    Grau JF; Farinas-Madrid L; Oaknin A
    Int J Gynecol Cancer; 2020 Jan; 30(1):139-143. PubMed ID: 31645423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases showing the effects of bevacizumab on recurrent cervical cancer with pleural effusion.
    Kamiya N; Matsunaga T; Miyagi E
    Int Cancer Conf J; 2022 Jul; 11(3):165-171. PubMed ID: 35669902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late recurrence of gastric cancer in the ovary and uterine cervix.
    Watanabe M; Hasegawa K; Kanamori A; Kiuchi K; Kuno T; Kosaka N; Fukasawa I; Imai Y
    Int Cancer Conf J; 2016 Oct; 5(4):206-213. PubMed ID: 31149456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma.
    Ho CM; Chien TY; Shih BY; Huang SH
    Gynecol Oncol; 2003 Mar; 88(3):394-9. PubMed ID: 12648592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.